Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East

Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East

Background: A growing body of evidence underscores the beneficial impact of therapeutic drug monitoring (TDM) on the efficacy and cost-effectiveness of anti-tumour necrosis factor (TNF) therapy in patients with inflammatory bowel disease (IBD). Objectives: We surveyed clinician attitudes, perception...

Full description

Bibliographic Details
Main Authors:	Gaurav B. Nigam, Kelly Chatten, Ala Sharara, Talal Al-Taweel, Othman Alharbi, Hussein Elamin, Sameer Al Awadhi, Vito Annese, Jimmy K. Limdi
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-02-01
Series:	Therapeutic Advances in Gastroenterology
Online Access:	https://doi.org/10.1177/17562848241230902

Similar Items

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
by: Sara Salvador-Martín, et al.
Published: (2021-10-01)

Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates
by: Vito Annese, et al.
Published: (2021-12-01)

Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs
by: Giulia Roda, et al.
Published: (2019-08-01)

Current perspectives on the diagnosis and management of functional anorectal disorders in patients with inflammatory bowel disease
by: Gaurav B. Nigam, et al.
Published: (2018-12-01)

Tofacitinib and newer JAK inhibitors in inflammatory bowel disease—where we are and where we are going
by: Eleanor Liu, et al.
Published: (2022-04-01)

Functional gastrointestinal disorders among healthcare professionals—hidden in plain sight?
by: Gaurav B. Nigam, et al.
Published: (2023-04-01)

Precision Medicine in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2023-08-01)

Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
by: Thomsen SF, et al.
Published: (2015-11-01)

A review of extraintestinal manifestations and complications of inflammatory bowel disease
by: Vito Annese
Published: (2019-01-01)

Patient Preferences for Ulcerative Colitis Treatment in the Middle East Region: A Discrete-Choice Experiment
by: Othman AlHarbi, et al.
Published: (2024-01-01)

Vedolizumab in the treatment of inflammatory bowel disease: evolving paradigms
by: Benjamin Crooks, et al.
Published: (2020-03-01)

Ca2+/Calmodulin-NOS/NO-TNFs Pathway Hallmarks the Inflammation Response of Oyster During Aerial Exposure
by: Hao Chen, et al.
Published: (2021-01-01)

Management of inflammatory bowel disease in older persons: evolving paradigms
by: Saurabh Kedia, et al.
Published: (2018-04-01)

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease
by: Taylor, PC, et al.
Published: (2023)

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease
by: Peter C. Taylor, et al.
Published: (2023-02-01)

Motherhood and fatherhood of patients with inflammatory rheumatic diseases in the era of biologics. Where are we after 20 years of anti-TNFs’ use?
by: Robert J. Moots, et al.
Published: (2015-12-01)

Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
by: Nesbitt A, et al.
Published: (2010-11-01)

Producing Hydrogen Energy Using Cr2O3-TNFs Nanocomposite with Animal (Chitosan) Extract via Ultrasonic and Hydrothermal Techniques
by: Ghasaq Z. Alwan, et al.
Published: (2022-09-01)

Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab
by: Yusuf Karabulut
Published: (2021-10-01)

Role of routine upper endoscopy before bariatric surgery in the Middle East population: a review of 1278 patients
by: Bassem Abou Hussein, et al.
Published: (2018-10-01)

Real-world outcomes associated with switching to anti-TNFs other biologics in Crohn’s Disease patients: A retrospective analysis using German claims data
by: Evi Zhuleku, et al.
Published: (2022-11-01)

Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future
by: Virginia Solitano, et al.
Published: (2022-01-01)

Gastroenterology team members’ knowledge and practices with fertility therapy for women with inflammatory bowel disease
by: Robyn Laube, et al.
Published: (2022-03-01)

Making social media work: finding a library voice
by: Zelda Chatten
Published: (2017-11-01)

Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease
by: Saad Alrajhi, et al.
Published: (2020-07-01)

Current Status and the Epidemiology of Malaria in the Middle East Region and Beyond
by: Mohammad Al-Awadhi, et al.
Published: (2021-02-01)

Strategic pathways and regulatory choices for effective GHG reduction in hydrocarbon based economy: Case of Oman
by: Yassine Charabi, et al.
Published: (2018-11-01)

Composition of the gut microbiota in patients with inflammatory bowel disease in Saudi Arabia: A pilot study
by: Hadba Al-Amrah, et al.
Published: (2023-01-01)

Exploring treatment of inflammatory bowel disease with infliximab in the Middle East and Northern Africa: An analysis of the HARIR observational cohort study
by: Othman Alharbi, et al.
Published: (2023-01-01)

Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium.
by: Banerjee, R, et al.
Published: (2022)

Spatial variation of the levels of deprivation in the Sultanate of Oman
by: Montaser Ibrahim Abdel Ghani, et al.
Published: (2016-01-01)

Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patients
by: Hanan Alatawi, et al.
Published: (2022-06-01)

The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom
by: Benjamin Crooks, et al.
Published: (2022-01-01)

Quality Metrics and Indicators in Colonoscopy
by: Halim Bou Daher, et al.
Published: (2018-09-01)

Sustainable Management of Climate Change: The Case of the Middle East and North Africa Region
by: Adel M. Al Taweel, et al.
Published: (2015-08-01)

Rheumatic manifestations of inflammatory bowel diseases A study from the Middle East
by: Mohammed Hammoudeh, et al.
Published: (2018-09-01)

Vedolizumab in Inflammatory Bowel Disease: West versus East
by: Prasanta Debnath, et al.
Published: (2021-01-01)

The Middle East/
by: Talal Asad, et al.
Published: (1983)

Mucosal Healing in Crohn’s Disease: Bull’s Eye or Bust? The “Relative” Con Position
by: Mahmoud Mosli, et al.
Published: (2021-10-01)

State-of-the-art management of acute bleeding peptic ulcer disease
by: Hisham Al Dhahab, et al.
Published: (2013-01-01)